Boston Scientific (BSX) is a health care equipment company in the Health Care sector. Listed on the NASDAQ, Boston Scientific is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $48.34.
Key Metrics & Risk
Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).
| Metric | Value |
|---|---|
| Latest Price | $48.34 |
| Latest Date | 2026-06-10 |
| Expected Return (Annualized) | 5.75% |
| Risk / Std Dev (Annualized) | 25.68% |
| Sharpe Ratio (rf=4.5%) | 0.05 |
S&P 500 Context
- Sector: Health Care
- Sub-Industry: Health Care Equipment
- Exchange: NASDAQ
- Index: S&P 500 Component
Risk/Return Profile
The stock shows an annualized expected return of 5.75% with an annualized volatility of 25.68%. The Sharpe ratio of 0.05 (assuming 4.5% risk-free rate) indicates below-average risk-adjusted returns relative to the risk-free rate.
Modern Portfolio Theory Positioning
This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.
Fundamentals
| Metric | Value |
|---|---|
| Market Cap | 71.85B |
| Enterprise Value | 81.67B |
| Trailing P/E | 20.23 |
| Forward P/E | 12.97 |
| Price to Book | 2.78 |
| Price to Sales | 3.49 |
| EV/Revenue | 3.96 |
| EV/EBITDA | 14.85 |
| Profitability | | | Profit Margin | 17.29% | | Operating Margin | 20.6% | | ROE | 14.66% | | ROA | 6.07% |
| Growth | | | Revenue Growth | 11.6% | | Earnings Growth | 100.0% |
| Financial Health | | | Total Revenue | 20.61B | | Total Debt | 11.03B | | Total Cash | 1.45B | | Free Cash Flow | 2.81B | | Operating Cash Flow | 4.34B |
| Price & Technical | | | 52W High | $109.5$ | | 52W Low | $47.17$ | | 50-Day Avg | $57.14$ | | 200-Day Avg | $83.27$ | | Beta | 0.56 | | Shares Outstanding | 1.49B | | Float Shares | 1.48B | | Insider Holdings | 0.23% | | Institutional Holdings | 95.03% | | Short Ratio | 2.71 | | Short % of Float | 3.87% |
| Analyst Targets | | | Target High | $106.0$ | | Target Low | $55.0$ | | Target Mean | $78.17$ | | Target Median | $76.5$ | | # of Analysts | 30 | | Recommendation | strong_buy |
Disclaimer
This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.